A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
In response to tenacious stress signals, such as the unscheduled activation of oncogenes, cells can mobilize tumour suppressor networks to avert the hazard of malignant transformation. A large body of evidence indicates that oncogene-induced senescence (OIS) acts as such a break, withdrawing cells from the proliferative pool almost irreversibly, thus crafting a vital pathophysiological mechanism that protects against cancer. Despite the widespread contribution of OIS to the cessation of tumorigenic expansion in animal models and humans, we have only just begun to define the underlying mechanism and identify key players. Although deregulation of metabolism is intimately linked to the proliferative capacity of cells, and senescent cells are thought to remain metabolically active, little has been investigated in detail about the role of cellular metabolism in OIS. Here we show, by metabolic profiling and functional perturbations, that the mitochondrial gatekeeper pyruvate dehydrogenase (PDH) is a crucial mediator of senescence induced by BRAF(V600E), an oncogene commonly mutated in melanoma and other cancers. BRAF(V600E)-induced senescence was accompanied by simultaneous suppression of the PDH-inhibitory enzyme pyruvate dehydrogenase kinase 1 (PDK1) and induction of the PDH-activating enzyme pyruvate dehydrogenase phosphatase 2 (PDP2). The resulting combined activation of PDH enhanced the use of pyruvate in the tricarboxylic acid cycle, causing increased respiration and redox st…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mitochondria in senescentcellsarelessfunctional,showingdecreasedmembrane potential, increased proton leak, reduced fusion and fission rates, increased mass, and abundance of tricarboxylic acid (TCA) cycle metabolites (Kaplon et al., 2013; Passos et al., 2010).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Kaplon et al., 2013
In the citing paper
“Senescent cells exhibit several changes in mitochondrial function, dynamics, and morphology.”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Kaplon et al., 2013
In the citing paper
“Targeting aspects of mitochondrial biology, such as the electron transport chain (ETC), complex I assembly, mitochondrial fission rates, and biogenesis, mitochondrial sirtuins and/or disruption of the TCA cycle can trigger senescence (Correia-Melo et al., 2016; Jiang et al., 2013; Kaplon et al., 2013; Miwa et al., 2014; Moiseeva et al., 2009; Park et al., 2010; Wiley et al., 2016).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Kaplon et al., 2013
In the citing paper
“In addition to the active protein metabolism described above, recent reports have shown that mitochondrial oxidative metabolism is up-regulated in senescent cells to support the metabolic demands of these cells (Dörr et al. 2013; Kaplon et al. 2013).”
From Cellular senescence and its effector programs (2014) · cites this paper as Kaplon et al. 2013
In the citing paper
“This revealed that pyruvate dehydrogenase (PDH) plays a key role in OIS.”
From Cellular senescence and its effector programs (2014) · cites this paper as Kaplon et al. 2013
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Self-citationOncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086
Self-citationThe essence of senescence: Figure 1.
Kuilman, T., Michaloglou, C., Mooi, W. J., & Peeper, D. S. (2010) · Genes & Development · doi:10.1101/gad.1971610 · Cited by 2,038
Self-citationFantin, V. R., St-Pierre, J., & Leder, P. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.023 · Cited by 1,635
Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity
Tsai, J., Lee, J. T., Wang, W., Zhang, J., Cho, H., Mamo, S., Bremer, R., Gillette, S., Kong, J., Haass, N. K., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711741105 · Cited by 1,346
Lowe, S. W., Cepero, E., & Evan, G. (2004) · Nature · doi:10.1038/nature03098 · Cited by 1,309
BrafV600E cooperates with Pten loss to induce metastatic melanoma
Dankort, D., Curley, D. P., Cartlidge, R. A., Nelson, B., Karnezis, A. N., Damsky Jr, W. E., You, M. J., DePinho, R. A., McMahon, M., & Bosenberg, M. (2009) · Nature Genetics · doi:10.1038/ng.356 · Cited by 1,189
Cited by
Items 201–300 of 653
Autophagy-mediated degradation of nuclear envelope proteins during oncogene-induced senescence
Lenain, C., Gusyatiner, O., Douma, S., van den Broek, B., & Peeper, D. S. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv124 · Cited by 61
“Some changes occur in the cytoplasm, such as altered metabolic activity (7,8) and increased autophagy (9,10), while others affect the nucleus, like the accumulation of senescenceassociated heterochromatic foci (SAHF) (11,12).”
BackgroundSelf-citationMoore, J. D., Staniszewska, A. D., Shaw, T., D’Alessandro, J., Davis, B. J., Surgenor, A., Baker, L. M., Matassova, N., Murray, J. B., Macias, A. T., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2656 · Cited by 66
“PDK has emerged as factor which fits well into the above paradigm in that it has been implicated in both the process of cellular transformation as well as a factor that is deregulated following the activation of common oncogenic signaling pathways [28, 29].”
BackgroundCellular senescence and protein degradation: Breaking down cancer
Deschênes-Simard, X., Lessard, F., Gaumont-Leclerc, M.-F., Bardeesy, N., & Ferbeyre, G. (2014) · Cell Cycle · doi:10.4161/cc.29335 · Cited by 61
Choi, J., Xu, M., Makowski, M. M., Zhang, T., Law, M. H., Kovacs, M. A., Granzhan, A., Kim, W. J., Parikh, H. M., Gartside, M. G., et al. (2017) · Nature Genetics · doi:10.1038/ng.3927 · Cited by 67
Senescence in the Development and Response to Cancer with Immunotherapy: A Double-Edged Sword
Battram, A. M., Bachiller, M., & Martín-Antonio, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124346 · Cited by 70
The role of mitochondrial electron transport in tumorigenesis and metastasis
Tan, A. S., Baty, J. W., & Berridge, M. V. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.10.016 · Cited by 76
Linking Cancer Metabolism to DNA Repair and Accelerated Senescence
Efimova, E. V., Takahashi, S., Shamsi, N. A., Wu, D., Labay, E., Ulanovskaya, O. A., Weichselbaum, R. R., Kozmin, S. A., & Kron, S. J. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0263 · Cited by 67
“Downregulation and/ormutation of TCA cycle enzymes are observed in cancer (38) and activation of the TCA cycle may promote senescence (39).”
Rethinking the biology of metastatic melanoma: a holistic approach
Vandyck, H. H., Hillen, L. M., Bosisio, F. M., van den Oord, J., Hausen, A. Z., & Winnepenninckx, V. J. L. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-09960-8 · Cited by 68
“Other PDK isoforms—PDK1 and PDK3— inhibit PDH as well, fueling Warburg effect in melanoma [133, 142].”
BackgroundGu, Y., Zhao, X., Zhang, N., Yang, Y., Yi, Y., Shao, Q.-H., Liu, M.-X., & Zhang, X.-L. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102577 · Cited by 70
Feng, J., Lian, Z., Xia, X., Lu, Y., Hu, K., Zhang, Y., Liu, Y., Hu, L., Yuan, K., Sun, Z., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.10.023 · Cited by 71
The Jekyll and Hyde of Cellular Senescence in Cancer
Demirci, D., Dayanc, B., Mazi, F. A., & Şentürk, Ş. (2021) · Cells · doi:10.3390/cells10020208 · Cited by 69
Osteocyte mitochondria regulate angiogenesis of transcortical vessels
Liao, P., Chen, L., Zhou, H., Mei, J., Chen, Z., Wang, B., Feng, J. Q., Li, G., Tong, S., Zhou, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46095-0 · Cited by 64
“Excessive ROS accumulation in mitochondria will secondarily lead to cell stress, including abnormal cell signaling, in fl ammation 47 , cellular senescence 48 , apoptosis 49 and necrosis 32 , which eventually weaken angiogenesis 50 .”
Liu, L., Cao, J., Zhao, J., Li, X., Suo, Z., & Li, H. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s226851 · Cited by 80
Cheruiyot, A., Li, S., Srivatsan, S. N., Ahmed, T., Chen, Y., Lemacon, D. S., Li, Y., Yang, Z., Wadugu, B. A., Warner, W. A., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-4016 · Cited by 69
Hu, H., Zhao, R., He, Q., Cui, C., Song, J., Guo, X., Zang, N., Yang, M., Zou, Y., Yang, J., et al. (2022) · The FASEB Journal · doi:10.1096/fj.202101988r · Cited by 65
Metabolic plasticity maintains proliferation in pyruvate dehydrogenase deficient cells
Rajagopalan, K. N., Egnatchik, R. A., Calvaruso, M. A., Wasti, A. T., Padanad, M. S., Boroughs, L. K., Ko, B., Hensley, C. T., Acar, M., Hu, Z., et al. (2015) · Cancer & Metabolism · doi:10.1186/s40170-015-0134-4 · Cited by 59
“synthesis [4, 5], apoptosis resistance [6, 7], and evasion of senescence during oncogenic transformation [8, 9].”
BackgroundCellular Senescence in Liver Disease and Regeneration
Ferreira-Gonzalez, S., Rodrigo-Torres, D., Gadd, V. L., & Forbes, S. J. (2021) · Seminars in Liver Disease · doi:10.1055/s-0040-1722262 · Cited by 59
Corpet, A., & Stucki, M. (2014) · Chromosoma · doi:10.1007/s00412-014-0469-6 · Cited by 63
Metabolomics and lipidomics in Caenorhabditis elegans using a single-sample preparation
Molenaars, M., Schomakers, B. V., Elfrink, H. L., Gao, A. W., Vervaart, M. A. T., Pras‐Raves, M. L., Luyf, A. C. M., Smith, R. L., Sterken, M. G., Kammenga, J. E., et al. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.047746 · Cited by 66
“…valuable for research in C. elegans , but could also be used to study processes in which pyruvate dehydrogenase is involved, such as the aberrant preferential activation of glycolysis in cancer cells (Kaplon et al., 2013) or the regulation of brown adipose tissue metabolism (Held et al., 2018).”
The Warburg effect and mitochondrial oxidative phosphorylation: Friends or foes?
Pinto, M. M., Paumard, P., Bouchez, C. L., Ransac, S., Duvezin‐Caubet, S., Mazat, J., Rigoulet, M., & Devin, A. (2022) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2022.148931 · Cited by 65
Targeting Glucose Metabolism in Cancer Cells as an Approach to Overcoming Drug Resistance
Cunha, A., Silva, P. M. A., Sarmento, B. F. C. C., & Queirós, O. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15112610 · Cited by 64
Mitochondrial pyruvate carrier function and cancer metabolism
Rauckhorst, A. J., & Taylor, E. B. (2016) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2016.05.003 · Cited by 61
Regulation of Cancer Metabolism by Deubiquitinating Enzymes: The Warburg Effect
Kim, S., & Baek, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126173 · Cited by 65
“However, when transport through the intracellular membrane attains the maximum rate, the shuttle exceeds the range that accommodates glycolysis and subsequently converts pyruvate to lactic acid via LDH to produce NAD+ [32].”
BackgroundOxidative Glucose Metabolism Promotes Senescence in Vascular Endothelial Cells
Stabenow, L. K., Zibrova, D., Ender, C., Helbing, D. L., Spengler, K., Marx, C., Wang, Z.-Q., & Heller, R. (2022) · Cells · doi:10.3390/cells11142213 · Cited by 56
“The glycolytic state has often been linked to an increased need for macromolecule building blocks required for senescence-associated events, such as senescence-associated secretory phenotype (SASP), cell enlargement or increased oxidative and endoplasmic reticulum stress, and has been thought to compensate for reduced…”
BackgroundResultInfluentialDelgado‐Goñi, T., Miniotis, M. F., Wantuch, S., Parkes, H. G., Marais, R., Workman, P., Leach, M. O., & Beloueche‐Babari, M. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0068 · Cited by 67
“Our data showed that the [4-(13)C]glutamate signal was always far greater than that from [2-(13)C] and [3-(13)C]glutamate, in keeping with PDH flux being the primary route for pyruvate entry into the TCA cycle in melanoma cells (27).”
ResultTanaka, H., Takebayashi, S., Sakamoto, A., Igata, T., Nakatsu, Y., Saitoh, N., Hino, S., & Nakao, M. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.021 · Cited by 62
Menon, D. R., Hammerlindl, H., Torrano, J., Schaider, H., & Fujita, M. (2020) · Theranostics · doi:10.7150/thno.42523 · Cited by 58
“Interestingly, PDK1 knockdown sensitizes BRAF-mutant melanoma to BRAF inhibitor treatment [132], suggesting the role of”
BackgroundInfluentialYuan, L., Zhai, L., Qian, L., Huang, D., Ding, Y., Xiang, H., Liu, X., Thompson, J. W., Liu, J., He, Y., et al. (2018) · Cell Research · doi:10.1038/s41422-018-0043-5 · Cited by 59
Nacarelli, T., Azar, A., Altinok, O., Orynbayeva, Z., & Sell, C. (2018) · GeroScience · doi:10.1007/s11357-018-0030-2 · Cited by 58
Overexpression of PDK2 and PDK3 reflects poor prognosis in acute myeloid leukemia
Cui, L., Cheng, Z., Liu, Y., Dai, Y., Pang, Y., Jiao, Y., Ke, X., Cui, W., Zhang, Q., Shi, J., et al. (2018) · Cancer Gene Therapy · doi:10.1038/s41417-018-0071-9 · Cited by 62
ROCK 1 is a potential combinatorial drug target for BRAF mutant melanoma
Smit, M. A., Maddalo, G., Greig, K., Raaijmakers, L. M., Possik, P. A., van Breukelen, B., Cappadona, S., Heck, A. J., Altelaar, A. M., & Peeper, D. S. (2014) · Molecular Systems Biology · doi:10.15252/msb.20145450 · Cited by 54
Self-citationRahman, A. M. A., Ryczko, M. C., Nakano, M., Pawling, J., Rodrigues, T., Johswich, A., Taniguchi, N., & Dennis, J. W. (2014) · Glycobiology · doi:10.1093/glycob/cwu105 · Cited by 61
“Increased lactate production is commonly observed in proliferating cells, along with high rates of oxidative respiration that require mechanisms of stress tolerance (Levine and Puzio-Kuter 2010; Kaplon et al. 2013).”
BackgroundDad, A., Jeong, C. H., Wagner, E. D., & Plewa, M. J. (2018) · Environmental Science & Technology · doi:10.1021/acs.est.7b04290 · Cited by 57
Understanding the Warburg Effect in Cancer
Li, Z., Munim, M. B., Sharygin, D. A., Bevis, B. J., & Heiden, M. G. V. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041532 · Cited by 64
Glucose metabolism and hexosamine pathway regulate oncogene-induced senescence
Gitenay, D., Wiel, C., Lallet-Daher, H., Vindrieux, D., Aubert, S., Payen, L., Simonnet, H., & Bernard, D. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.63 · Cited by 52
Next-Generation in vivo Modeling of Human Cancers
Gargiulo, G. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00429 · Cited by 60
Diverse Roles of Cellular Senescence in Skeletal Muscle Inflammation, Regeneration, and Therapeutics
Saito, Y., & Chikenji, T. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.739510 · Cited by 57
Ferriero, R., Iannuzzi, C., Manco, G., & Brunetti‐Pierri, N. (2015) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-014-9808-2 · Cited by 55
Molecular mechanisms of ageing and related diseases
Liu, J. (2014) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12247 · Cited by 56
“active form of PDH without phosphorylation increases the use of pyruvate in the tricarboxylic acid (TCA) cycle (or the Krebs’ cycle), causing elevated respiration and redox stress and thus cell senescence.(24) Enforced normalization of either PDK1 or PDP2 expression inhibits PDH and abrogates OIS, thereby permitting B…”
BackgroundLou, X., Zhang, J., Liu, S., Lou, X., & Liao, D. J. (2014) · Cell Cycle · doi:10.4161/cc.29082 · Cited by 51
Shi, X., Tasdogan, A., Huang, F., Hu, Z., Morrison, S. J., & DeBerardinis, R. J. (2017) · Science Advances · doi:10.1126/sciadv.aao5268 · Cited by 47
Inhibition of nucleotide synthesis promotes replicative senescence of human mammary epithelial cells
Delfarah, A., Parrish, S., Junge, J. A., Yang, J., Seo, F., Li, S., Mac, J., Wang, P., Fraser, S. E., & Graham, N. A. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005806 · Cited by 51
“Similarly, senescence induced by oncogene activation also leads to increased glycolysis (8, 16).”
BackgroundMissios, P., Zhou, Y., Guachalla, L. M., von Figura, G., Wegner, A., Chakkarappan, S. R., Binz, T., Gompf, A., Hartleben, G., Burkhalter, M. D., et al. (2014) · Nature Communications · doi:10.1038/ncomms5924 · Cited by 46
Cheng, X. F., Yao, X., Xu, S., Pan, J., Yu, H., Bao, J., Guan, H., Lu, R., & Zhang, L. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.074 · Cited by 50
Cancer Response to Therapy-Induced Senescence: A Matter of Dose and Timing
Mongiardi, M. P., Pellegrini, M., Pallini, R., Levi, A., & Falchetti, M. L. (2021) · Cancers · doi:10.3390/cancers13030484 · Cited by 53
Novel Therapeutic Targets of Tumor Metabolism
Kishton, R. J., & Rathmell, J. C. (2015) · The Cancer Journal · doi:10.1097/ppo.0000000000000099 · Cited by 50
Elevated expression of TrpC5 and GLUT1 is associated with chemoresistance in colorectal cancer
Wang, T., Ning, K., Lu, T., & Hua, D. (2016) · Oncology Reports · doi:10.3892/or.2016.5322 · Cited by 49
“As one of the 10 hallmarks of cancer (2), aerobic glycolysis plays an important role in cancer proliferation, metastasis and angiogenesis (3-9).”
BackgroundCraveiro, M., Cretenet, G., Mongellaz, C., Matias, M. I., Caron, O., de Lima, M. C. P., Zimmermann, V. S., Solary, É., Dardalhon, V., Dulić, V., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aal3024 · Cited by 52
Yang, W., Pang, D., Chen, M., Du, C., Jia, L., Wang, L., He, Y., Jiang, W., Luo, L., Yu, Z., et al. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.02.022 · Cited by 57
Immunometabolism and oxidative stress: roles and therapeutic strategies in cancer and aging
Zhou, N.-J., Bao, W.-Q., Zhang, C., Jiang, M., Liang, T.-L., Ma, G.-Y., Liu, L., Pan, H., & Li, R.-Z. (2025) · npj Aging · doi:10.1038/s41514-025-00250-z · Cited by 50
“Additionally, metabolic reprogramming and oxidative stressform a positivefeedback loop: enhancedglycolysisin senescent cells increases mitochondrial ROS accumulation 106,107 , while cancer cells sustainhigh ROSlevelsviatheWarburg effect, promoting proliferationand inhibiting apoptosis 108 .”
Energy metabolism in skin cancers: A therapeutic perspective
Hosseini, M., Kasraian, Z., & Rezvani, H. R. (2017) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2017.01.013 · Cited by 50
Audrito, V., Managò, A., Gaudino, F., & Deaglio, S. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.001 · Cited by 51
TGF-β/NF1/Smad4-mediated suppression of ANT2 contributes to oxidative stress in cellular senescence
Kretová, M., Sabová, L., Hodný, Z., Bártek, J., Kollárovič, G., Nelson, B. D., Hubáčková, S., & Luciaková, K. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.08.029 · Cited by 46
Abildgaard, C., Dahl, C., Basse, A. L., Ma, T., & Guldberg, P. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0247-5 · Cited by 49
“DCA promotes PDKdependent activation of PDH, reversing lactate production in favor of influx of pyruvate into the mitochondria [15,18].”
InfluentialPapillary Thyroid Microcarcinoma
Soares, P., Celestino, R., da Rocha, A. G., & Sobrinho-Simões, M. A. (2014) · International Journal of Surgical Pathology · doi:10.1177/1066896913517394 · Cited by 46
“Recent results obtained in melanoma suggest that BRAF oncogenic addiction, that is, the BRAF carcinogenic effect, resides in the remodeling of the metabolism of cancer cells,(28,29) thus indicating that the malignant behavior associated to BRAF mutation is not driven by the mutation per se but by its interaction with…”
BackgroundOxidative stress-induced senescence markedly increases disc cell bioenergetics
Patil, P. R., Falabella, M., Saeed, A., Lee, D., Kaufman, B. A., Shiva, S., Croix, C. M. S., Houten, B. V., Niedernhofer, L. J., Robbins, P. D., et al. (2019) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2019.04.006 · Cited by 47
Gao, S., Sun, H., Jiang, H., Li, L., Hu, X., Xu, X., & Jin, W. (2015) · Oncotarget · doi:10.18632/oncotarget.6222 · Cited by 47
“Emerging evidence indicates that glucose metabolism also shifts in senescent cells [25-27].”
BackgroundSingh, K., Krug, L., Basu, A., Meyer, P., Treiber, N., Vander Beken, S., Wlaschek, M., Kochanek, S., Bloch, W., Geiger, H., et al. (2017) · Stem Cells · doi:10.1002/stem.2629 · Cited by 43
Keeping zombies alive: The ER-mitochondria Ca2+ transfer in cellular senescence
Ahumada-Castro, U., Puebla-Huerta, A., Cuevas-Espinoza, V., Lovy, A., & Cárdenas, C. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.119099 · Cited by 47
Lee, M. Y., Leonardi, A., Begley, T. J., & Melendez, J. A. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101375 · Cited by 44
“Thus, defects in the ALKBH family activity cause mitochondrial dysfunction with the potential to increase ROS production promote DNA damage and senescence growth arrest [53].”
BackgroundPossik, P. A., Müller, J., Gerlach, C., Kenski, J. C. N., Huang, X., Shahrabi, A., Krijgsman, O., Song, J., Smit, M. A., Gerritsen, B., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.024 · Cited by 47
Self-citationPrabhu, A. H., Sarcar, B., Miller, C. R., Kim, S.-H., Nakano, I., Forsyth, P. A., & Chinnaiyan, P. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nou369 · Cited by 44
“Recent discoveries involving the mechanistic underpinnings of oncogene-induced senescence represent one of the most notable examples describing this important interplay between a driver mutation and its functional, metabolic consequence.(36) In these studies, it was shown that PDH was a crucial mediator of senescence…”
BackgroundRuiz, N. P. E., Mohan, V., Wu, J., Scott, S. A., Kreamer, M., Benej, M., Golias, T., Papandreou, I., & Denko, N. C. (2021) · Cancer & Metabolism · doi:10.1186/s40170-021-00275-4 · Cited by 46
“Recent studies have linked altered PDC function to metabolic diseases, response to ischemic injury and cancer [2-5].”
BackgroundJames, E. L., Lane, J. A. E., Michalek, R. D., Karoly, E. D., & Parkinson, E. K. (2016) · Scientific Reports · doi:10.1038/srep38489 · Cited by 40
Li, C., Liu, C., Zhang, J., Lu, Y., Jiang, B., Xiong, H., & Li, C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1296687 · Cited by 42
“PDK1 restricts the conversion of pyruvate to acetyl-CoA, which enters the TCA cycle and produces NADH, and blocks OXPHOS in mitochondria (39, 40).”
BackgroundCellular senescence: from anti-cancer weapon to anti-aging target
Yuan, L., Alexander, P. B., & Wang, X. (2020) · Science China Life Sciences · doi:10.1007/s11427-019-1629-6 · Cited by 43
Sreekumar, P. G., Reddy, S. T., Hinton, D. R., & Kannan, R. (2022) · Experimental Eye Research · doi:10.1016/j.exer.2021.108918 · Cited by 46
Pyruvate stimulates mitophagy via PINK1 stabilization
Park, S., Choi, S.-G., Yoo, S., Nah, J., Jeong, E., Kim, H.-J., & Jung, Y. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.05.020 · Cited by 43
Yang, X., Cheng, Y., Zhou, J., Zhang, L., Li, X., Wang, Z., Yin, S., Zhai, L., Huang, T., Wu, X., et al. (2022) · Advanced Science · doi:10.1002/advs.202104472 · Cited by 49
DNA damage response(DDR): a link between cellular senescence and human cytomegalovirus
Wu, X., Zhou, X., Wang, S., & Mao, G. (2023) · Virology Journal · doi:10.1186/s12985-023-02203-y · Cited by 49
“Furthermore, mitochondrial dysfunction induces increased ROS generation in senescent cells, resulting in DNA damage and DDR activation [74, 75], which drives cellular senescence [76, 77].”
BackgroundTso, S.-C., Lou, M., Wu, C., Gui, W. J., Chuang, J. L., Morlock, L., Williams, N. S., Wynn, R., Qi, X., & Chuang, D. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01540 · Cited by 41
Mitochondrial Bioenergetics and Dynamics in Secretion Processes
Martínez, J., Marmisolle, I., Tarallo, D., & Quijano, C. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00319 · Cited by 46
The NSD2/WHSC1/MMSET methyltransferase prevents cellular senescence‐associated epigenomic remodeling
Tanaka, H., Igata, T., Etoh, K., Koga, T., Takebayashi, S., & Nakao, M. (2020) · Aging Cell · doi:10.1111/acel.13173 · Cited by 44
“Cellular metabolism likely plays a crucial role in regulating SASP because abnormal activation of mitochondria increases the expression of a subset of secretory proteins and promotes senescence (CorreiaMelo et al., 2016; Kaplon et al., 2013; Quijano et al., 2012).”
BackgroundActivatable senoprobes and senolytics: Novel strategies to detect and target senescent cells
Morsli, S., Doherty, G. J., & Muñoz-Espín, D. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111618 · Cited by 42
Clinical impact of the Warburg effect in gastrointestinal cancer (Review)
Sawayama, H., Ishimoto, T., Sugihara, H., Miyanari, N., Miyamoto, Y., Baba, Y., Yoshida, N., & Baba, H. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2563 · Cited by 48
Wei, Y., Ding, J., Li, J., Cai, S., Liu, S., Hong, L., Yin, T., Zhang, Y., & Diao, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.717014 · Cited by 44
“It is the first in the world to use 24-well or 96-well microwell plates as a platform, which can record the extracellular acidification rate (ECAR) and oxygen consumption rate (OCR) in real-time as key metabolic readings and provide indirect measurements of glycolysis and mitochondria respiration (20).”
BackgroundMitochondria and senescence: new actors for an old play
Herranz, N., & Gil, J. (2016) · The EMBO Journal · doi:10.15252/embj.201694025 · Cited by 34
“This is in agreement with previous results from the Peeper laboratory, which reported that an increase of mitochondrial respiration through activation of pyruvate dehydrogenase (PDH) was required for the execution of oncogene-induced senescence (OIS) (Kaplon et al , 2013).”
InfluentialGRIM-19: A master regulator of cytokine induced tumor suppression, metastasis and energy metabolism
Nallar, S. C., & Kalvakolanu, D. V. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.09.001 · Cited by 42
Targeting glucose metabolism to develop anticancer treatments and therapeutic patents
Zhou, Y., Guo, Y., & Tam, K. Y. (2022) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2022.2027912 · Cited by 40
“In addition, 2–1 has been found to exert synergistic anticancer effects when combined with several cancer drugs including Vemurafenib [60], Gefitinib or Erlotinib [61], and Metformin Cl ONa Cl O DCA 2-1 R1O OR3 OR2 2-2 Cl Cl O O O OO NH2 O Cl Cl O 2-3 Cl Cl O O O OO ClCl O NH2 O 2-4 HO OH N O R1 R3 R2 2-6 HO OH N O Cl…”
BackgroundMetabolic alterations accompanying oncogene-induced senescence
Aird, K. M., & Zhang, R. (2014) · Molecular & Cellular Oncology · doi:10.4161/23723548.2014.963481 · Cited by 39
“1).(42,51) Oxidative phosphorylation is one of the most important biological processes of the mitochondrion.”
BackgroundInfluentialJian, B., Yang, S., Chaudry, I. H., & Raju, R. (2014) · Molecular Medicine · doi:10.2119/molmed.2013.00077 · Cited by 38
Sharkia, I., Erlich, T. H., Landolina, N., Assayag, M., Motzik, A., Rachmin, I., Kay, G., Porat, Z., Tshori, S., Berkman, N., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.09.047 · Cited by 41
Yuan, S., Yu, Z., Zhang, Z., Zhang, J., Zhang, P., Li, X., Li, H., Shen, H., & Chen, G. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.05.004 · Cited by 40
Cellular senescence signaling in cancer: A novel therapeutic target to combat human malignancies
Fakhri, S., Moradi, S. Z., DeLiberto, L. K., & Bishayee, A. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114989 · Cited by 42
3D functional and perfusable microvascular networks for organotypic microfluidic models
Bersini, S., & Moretti, M. (2015) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-015-5520-5 · Cited by 45
Integration of Mitochondrial Targeting for Molecular Cancer Therapeutics
Marchetti, P., Guerreschi, P., Mortier, L., & Kluza, J. (2015) · International Journal of Cell Biology · doi:10.1155/2015/283145 · Cited by 41
“could be proposed: (i) mobilization of mitochondrial biogenesis through reactivation of the MITF-PGC-1α pathway [45, 47], which appears to also be controlled by mTORC1/2 [35]; (ii) inhibition of the HIF-1α/PDK pathway [5, 50], the major gatekeeper of mitochondrial activity in melanoma [90]; and (iii) decreased HK2 exp…”
BackgroundRichard, E., Gallego‐Villar, L., Rivera‐Barahona, A., Oyarzábal, A., Pérez, B., Rodríguez‐Pombo, P., & Desviat, L. R. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/1246069 · Cited by 45
“Apart from the canonical ROS-producing sites in mitochondrial electron transfer chain, several reports pointed towards the important role of mitochondrial 2-oxoacid dehydrogenase complexes (2-oxoglutarate dehydrogenase, pyruvate dehydrogenase, and BCKDH) that share the E3 dihydrolipoamide dehydrogenase, as major O2 /H…”
BackgroundGiuliani, A., Giudetti, A. M., Vergara, D., Coco, L. D., Ramini, D., Caccese, S., Sbriscia, M., Graciotti, L., Fulgenzi, G., Tiano, L., et al. (2023) · Antioxidants · doi:10.3390/antiox12111956 · Cited by 45
“Interestingly, an increased rate of FAO was observed also in models of senescence induced by stimuli other than replication arrest, such as oncogene-induced senescence (OIS) [27,28].”
BackgroundMetabolic Alterations in Cellular Senescence: The Role of Citrate in Ageing and Age-Related Disease
Mycielska, M. E., James, E. N., & Parkinson, E. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073652 · Cited by 40
“This is achieved by increasing levels of PDP2 and decreasing the levels of PDK1 and these phenotypes were reversed upon abrogation of the senescent phenotype by enforced normalization of PDK1 through over-expression or the knockdown of PDP2 using shRNA [71].”
BackgroundInfluentialSenescence in cancer: Advances in detection and treatment modalities
Billimoria, R., & Bhatt, P. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115739 · Cited by 38
Disruptive chemicals, senescence and immortality
Carnero, A., Blanco-Aparicio, C., Kondoh, H., Lleonart, M. E., Martinez-Leal, J. F., Mondello, C., Scovassi, A. I., Bisson, W. H., Amedei, A., Roy, R., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv029 · Cited by 29
Oyarzábal, A., Bravo‐Alonso, I., Sánchez‐Aragó, M., Rejas, M. T., Merinero, B., García‐Cazorla, À., Artuch, R., Ugarte, M., & Rodríguez‐Pombo, P. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.01.016 · Cited by 44
Shakoor, A., Wang, B., Fan, L., Kong, L., Gao, W., Sun, J., Man, K., Li, G., & Sun, D. B. (2021) · Small · doi:10.1002/smll.202103086 · Cited by 42
Role of Oxidative Stress in the Senescence Pattern of Auditory Cells in Age-Related Hearing Loss
Chacón, L. D. M. R., Martínez-Rodríguez, S., Madrid, R., Yanes‐Diaz, J., Riestra‐Ayora, J., Fernández, R. S., & Sánchez‐Rodríguez, C. (2021) · Antioxidants · doi:10.3390/antiox10091497 · Cited by 42
“In general, the number of mitochondria increases in senescent cells [17,26,27].”
BackgroundMitochondria pleiotropism in stem cell senescence: Mechanisms and therapeutic approaches
Mas‐Bargues, C. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.09.019 · Cited by 39
p53 enables metabolic fitness and self-renewal of nephron progenitor cells
Li, Y., Liu, J., Li, W., Brown, A. C., Baddoo, M., Li, M. M., Carroll, T. J., Oxburgh, L. H., Feng, Y., & Saifudeen, Z. R. (2015) · Development · doi:10.1242/dev.111617 · Cited by 48
“…(PDH) complex through phosphorylation; it might thereby alter the metabolite flux by altering the activity of PDH, which converts pyruvate to acetyl-CoA (Kaplon et al., 2013) Dld 1.3 Component of the pyruvate dehydrogenase complex and the α-ketoglutarate dehydrogenase complex (Brown et al.,…”
BackgroundInfluentialLiang, Q.-H., Li, Q.-R., Chen, Z., Lv, L., Lin, Y., Jiang, H.-L., Wang, K., Xiao, M.-Y., Kang, N.-X., Tu, P., et al. (2023) · Inflammation Research · doi:10.1007/s00011-023-01840-x · Cited by 38
“Pyruvate dehydrogenase (PDH) catalyzes the conversion of cytosolic pyruvate to mitochondrial acetyl-CoA [38].”
Hamabe, A., Yamamoto, H., Konno, M., Uemura, M., Nishimura, J., Hata, T., Takemasa, I., Mizushima, T., Nishida, N., Kawamoto, K., et al. (2014) · Cancer Science · doi:10.1111/cas.12487 · Cited by 41
Targeting metabolic reprogramming as a potential therapeutic strategy in melanoma
Smith, L. K., Rao, A. D., & McArthur, G. A. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.02.009 · Cited by 38
Aldosterone from endometrial glands is benefit for human decidualization
Li, S., Song, Z., Yan, Y., Li, B., Song, M., Liu, Y., Yang, Z., Liu, A., Liu, A.-X., Quan, S., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02844-9 · Cited by 37
Metadata
- Authors
- Kaplon, J., Zheng, L., Meissl, K., Chaneton, B., Selivanov, V. A., Mackay, G., van der Burg, S. H., Verdegaal, E. M. E., Cascante, M., Shlomi, T., Gottlieb, E., & Peeper, D. S.
- Affiliations
- The Netherlands Cancer Institute (NL)
- Cancer Research UK Scotland Institute (GB)
- Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES)
- Technion – Israel Institute of Technology (IL)
- Corresponding author
- Gottlieb, Eyal
- Peeper, Daniel S.
- ORCID
- Venue
- Nature
- Published
- 2013-05-19
- Volume
- 498
- Issue
- 7452
- Pages
- 109-112
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2164524616
- Cited by
- 633
- References
- 33
- Citations by year
- 2026: 25 · 2025: 38 · 2024: 38 · 2023: 49 · 2022: 51 · 2021: 55 · 2020: 47 · 2019: 43 · 2018: 38 · 2017: 58 · 2016: 59 · 2015: 56 · 2014: 56 · 2013: 18
- FWCI
- 43.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Funders
- Cancer Research UK
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- oncogene-induced senescence, pyruvate dehydrogenase, pyruvate dehydrogenase kinase 1, PDP2, BRAF V600E mutation, melanoma, glucose oxidation, glycolysis, oxidative phosphorylation, mitochondrial metabolism, senescence-associated secretory phenotype, senescence-associated heterochromatin foci, senescence-associated DNA damage
- MeSH terms
- Pyruvate Dehydrogenase Acetyl-Transferring Kinase, Animals, Cell Line, Citric Acid Cycle, Disease Models, Animal, Enzyme Activation, Glycolysis, Humans, Melanoma, Mitochondria, Oncogenes, Oxidative Phosphorylation, Pyruvate Dehydrogenase Complex, Pyruvate Dehydrogenase (Lipoamide)-Phosphatase, Signal Transduction, Mice, SCID, Mice, Inbred NOD, Cellular Senescence, Protein Serine-Threonine Kinases, Proto-Oncogene Proteins B-raf, Mice, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.